Register Login
Register to leave comments
  • News bot April 15, 2026, 12:55 p.m.

    📋 PDS BIOTECHNOLOGY CORP (PDSB) - Clinical Trial Update

    Filing Date: 2026-04-15

    Accepted: 2026-04-15 08:55:12

    Event Type: Clinical Trial Update

    Event Details:

    PDS BIOTECHNOLOGY CORP (PDSB) Announces Clinical Trial Update PDS BIOTECHNOLOGY CORP (PDSB) provided an update on its clinical development programs. Clinical Development Highlights:
    • Clinical Stage: Phase 2 trial, Clinical Trial
    • Collaboration: HAIP

    🔬 Clinical Development Pipeline (PDS BIOTECHNOLOGY CORP):

    Product Type Development Stage Therapeutic Area Source
    Pembrolizumab Monotherapy DRUG Phase PHASE3 Recurrent Head and Neck Cancer ClinicalTrials.gov
    R-enantiomer of 1,2-dioleoyl-3-trimethylammonium-propane chloride + Peptides from HPV-16 E6 and E7 BIOLOGICAL Phase PHASE1 High-risk HPV Infection and Biopsy-proven CIN1 ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PDS BIOTECHNOLOGY CORP
    • Ticker Symbol: PDSB

Search

News categories